Sanofi Consumer Healthcare India Ltd - Stock Valuation and Financial Performance

BSE: 544250 | NSE: SANOFICONR | Pharmaceuticals & Drugs |

Sanofi Cons. Health Share Price

4,830 58.25 1.22%
as on 08-Apr'25 09:25

DeciZen - make an informed investing decision on Sanofi Cons. Health

M-Cap below 100cr DeciZen not available

Sanofi Consumer Healthcare India stock performance -

P/E Ratio (SA):
Market Cap:
0 Cr.
52-wk low:
4,360.3
52-wk high:
5,499

Is Sanofi Consumer Healthcare India Ltd an attractive stock to invest in?

1. Is Sanofi Consumer Healthcare India Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sanofi Consumer Healthcare India Ltd is a below average quality company.

2. Is Sanofi Consumer Healthcare India Ltd undervalued or overvalued?

The key valuation ratios of Sanofi Consumer Healthcare India Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Sanofi Consumer Healthcare India Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sanofi Consumer Healthcare India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sanofi Cons. Health:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sanofi Consumer Healthcare India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 0.00%

Latest Financials - Sanofi Consumer Healthcare India Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) 4360.30 / 5499.00
All Time Low / High (₹) 4360.30 / 5499.00
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Quarterly Results

 Dec'23 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 225 N/A164 63.9160 -24171 -24
Adj EPS (₹) 27.7 N/A20 78.319.9 -35.620.1 -27.2
Op. Profit Mgn % 39.85 N/A38.69 409 bps39.46 -552 bps36.38 -347 bps
Net Profit Mgn % 30.79 N/A27.99 227 bps28.67 -519 bps27.14 -365 bps

Management X-Ray of Sanofi Cons. Health:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:60.4%Institutions:29.57%Non-Institutions:10.04%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep24Dec240%10%20%30%40%50%60%70%
Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sanofi Cons. Health

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Sanofi Cons. Health

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Sun Pharma Inds. 1,697.9 29.5 (1.8%) Large Cap 48,497 47.7 20.9 35 5.6
Dr. Reddys Lab 1,108.4 19.8 (1.8%) Large Cap 28,011 64.4 19.6 16.9 2.8
Cipla 1,426.1 41.7 (3%) Large Cap 25,774 61.8 15.6 22.4 3.7
Lupin 1,984.7 61.8 (3.2%) Mid Cap 20,011 62.8 9.7 30.6 5.3
Zydus Lifesciences 860.2 22.8 (2.7%) Large Cap 19,547 45.1 19.3 18.6 3.7
Glenmark Pharma 1,438.3 -3 (-0.2%) Mid Cap 11,813 -6.2 -10.2 - 4.6
Torrent Pharma 3,227.9 -4.7 (-0.2%) Large Cap 10,728 55 14.8 58.8 13.7
Aurobindo Pharma 1,099.3 4.2 (0.4%) Mid Cap 10,646 33 17.2 33.2 3.2
Alkem Laboratories 4,831.2 131.2 (2.8%) Mid Cap 9,748 190.9 18.1 24.6 4.5
Mankind Pharma 2,415.1 36.7 (1.5%) Mid Cap 9,265 47.4 19.6 50.1 6.9
Shows rows:

Profit And Loss

(All Figures are in Crores.)
No data found!

Balance Sheet

(All Figures are in Crores.)
No data found!

Cash Flow

(All Figures are in Crores.)
No data found!
No data found!

Sanofi Consumer Healthcare India Ltd Stock News

Sanofi Consumer Healthcare India Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Sanofi Cons. Health on 08-Apr-2025 09:25 is ₹4,830.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 08-Apr-2025 09:25 the market cap of Sanofi Cons. Health stood at ₹0.00.
The latest P/E ratio of Sanofi Cons. Health as of 08-Apr-2025 09:25 is 0.00.
The latest P/B ratio of Sanofi Cons. Health as of 08-Apr-2025 09:25 is 0.00.
The 52-week high of Sanofi Cons. Health is ₹5,499 and the 52-week low is ₹4,360.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi Cons. Health is ₹0.00 ( Cr.) .

About Sanofi Consumer Healthcare India Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...